Medicine
More
-
May 3- The U.S. Food and Drug Administration approved a Merck& Co. cholesterol lowering pill that combines a generic version of Pfizer Inc's Lipitor with its own Zetia, Merck said on Friday. Vytorin, which had sales of $1.75 billion in 2012, is currently undergoing a long-term trial to prove that it can reduce heart attacks and strokes better than Zocor alone.
-
FRANKFURT, May 3- Eli Lilly, the world's fourth-largest diabetes drugs maker, aims to have the widest range of anti diabetic drugs in order to win a larger slice in the growing market.
-
*Aiming to win bigger slice of growing market* Lilly currently No.4 in $40 bln diabetes market* Lilly says mainly addressing GPs, not specialists By Ludwig Burger and Frank Siebelt. FRANKFURT, May 3- Eli Lilly, the world's fourth-largest diabetes drugs maker, aims to have the widest range of anti diabetic drugs in order to win a larger slice in the growing market.
-
Lawyers with the Justice Department filed the appeal with the 2nd U.S. Circuit Court of Appeals in New York, according to court documents. District Judge Edward Korman's ruling from April 5 that required the FDA to make the emergency contraception available over-the-counter to women of all ages within 30 days.
-
May 2- Gilead Sciences Inc said on Thursday that its quarterly profit rose 63 percent as lower sales of its older HIV drugs were offset by strong sales of new products, but the results fell slightly short of Wall Street estimates.
-
May 2- Gilead Sciences Inc said on Thursday its quarterly profit rose 63 percent as lower sales of the company's older HIV drugs were offset by higher sales of new products and overall revenue rose 11 percent.
-
May 2- Arena Pharmaceuticals Inc withdrew an application to market its anti-obesity drug in the European Union, sending its shares down 15 percent in after-hours trading.
-
May 2- A panel of advisers to the U.S. health regulator unanimously recommended against approving Delcath Systems Inc's cancer therapy for a rare form of eye cancer that spreads to the liver, saying it was too risky.
-
May 2- A panel of advisers to the U.S. health regulator said that risks outweighed the benefits in Delcath Systems Inc's cancer therapy for a rare form of eye cancer that spreads to the liver. The panel of independent experts voted 16-0 against the drug/device combination.
-
May 2- Gilead Sciences Inc said on Thursday its quarterly profit rose 63 percent as lower sales of the company's older HIV drugs were offset by higher sales of new products and overall revenue rose 11 percent.
-
*New bird flu strain has killed 27 people in China. LONDON, May 2- Human cases of a deadly new strain of bird flu that has killed 27 people in China are likely to crop up in Europe and around the world but that should not cause undue alarm, Europe's leading flu expert said on Thursday.
-
May 2- Gilead Sciences Inc on Thursday said almost all patients taking a fixed-dose combination of two of its experimental hepatitis C drugs appeared to have eliminated the liver virus after either 8 weeks or 12 weeks of treatment in a small mid-stage study.
-
May 2- Gilead Sciences Inc on Thursday said almost all patients taking a fixed-dose combination of two of its experimental hepatitis C drugs appeared to have eliminated the liver virus after either 8 weeks or 12 weeks of treatment in a small mid-stage study.
-
May 2- Gilead Sciences Inc on Thursday said almost all patients taking a fixed-dose combination of two of its experimental hepatitis C drugs appeared to have eliminated the liver virus after either 8 weeks or 12 weeks of treatment in a small mid-stage study.
-
May 2- Gilead Sciences Inc on Thursday said almost all patients taking a fixed-dose combination of two of its experimental hepatitis C drugs appeared to have eliminated the liver virus after either 8 weeks or 12 weeks of treatment in a small mid-stage study.
-
An antibiotic-resistant strain of gonorrhea has some saying that its effects could match those of AIDS.
-
May 2- Eli Lilly and Co:. *Boehringer ingelheim pharmaceuticals, inc. and Eli Lilly and Company launch. educational campaign about emerging science in type 2 diabetes.
-
DUBAI, May 2- Saudi Arabia said five more people have died of a deadly new virus from the same family as SARS, and two other people were in intensive care. The seven cases were discovered in al-Ahsa governorate in the Eastern Province, the Saudi news agency SPA quoted the Saudi Health Ministry as saying in a statement late on Wednesday.
-
BEIJING, May 2- A 55- year-old man in central China has died from a new strain of bird flu, bringing to 27 the number of deaths from the mysterious H7N9 virus, state news agency Xinhua said on Thursday. The H7N9 virus, which has infected 127 people in China, is a threat to world health and should be taken seriously, scientists said on Wednesday.
-
By Ransdell Pierson and Bill Berkrot. May 2- Gilead Sciences Inc on Thursday said almost all patients taking a fixed-dose combination of two of its experimental hepatitis C drugs appeared to have eliminated the liver virus after either eight weeks or 12 weeks of treatment in a small mid-stage study.